retatrutide safety clinical trial retatrutide ⚠️ “RETA” is NOT an approved weight-loss medication. Social media is full of “RETA” offers—but here's what you should know. is a promising investigational medicine developed by Eli Lilly. The Phase Retatrutide Availability & Timeline |

Larazotide is studied as a zonulin antagonist / tight-junction regulator : in mechanistic work it is associated with promoting the reassembly of tight-junction proteins and the underlying actin cytoskeleton, blunting the gliadin- and zonulin-induced rise in permeability [4] [5]

A multivariable logistic regression model showed that a higher frequency of red and processed meat consumption was significantly associated with an increased risk of thyroid autoimmunity, as indicated by TPOAb positivity

and PRIME/H2020-SC1-BHC-2018-2020, ref

Patients considering BPC-157 should be aware that using unlicensed substances carries inherent risks, including unknown side effects, lack of quality control, and potential interactions with prescribed medications

Pancreatitis with use of new diabetic medications: a real-world data study using the post-marketing FDA adverse event reporting system (FAERS) database